@article {6787,
	title = {Re: Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE)},
	journal = {European Urology},
	volume = {70},
	year = {2016},
	note = {Cited By :2Export Date: 19 March 2018},
	month = {2016},
	pages = {892},
	url = {https://www.scopus.com/inward/record.uri?eid=2-s2.0-84994300338\&doi=10.1016\%2fj.eururo.2016.08.027\&partnerID=40\&md5=767675236ae208f3e9878f8c1dacca08},
	author = {Cruz, F.}
}
